0001209191-20-038142.txt : 20200622 0001209191-20-038142.hdr.sgml : 20200622 20200622161250 ACCESSION NUMBER: 0001209191-20-038142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200618 FILED AS OF DATE: 20200622 DATE AS OF CHANGE: 20200622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARUSO RICHARD E CENTRAL INDEX KEY: 0001187576 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 20978921 MAIL ADDRESS: STREET 1: 311 C ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-18 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001187576 CARUSO RICHARD E 795 E LANCASTER AVENUE, SUITE 200 VILLANOVA PA 19085 0 0 1 0 Common Stock 163668 D Common Stock 2020-06-18 4 S 0 600000 48.47 D 10291205 I By Partnership Common Stock 4000 I By Son Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $48.57 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. /s/ Gary DiLella; Power of Attorney 2020-06-22 EX-24 2 attachment1.htm EX-24 DOCUMENT








POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby authorizes
Gary DiLella and Gerald N. Holtz to execute for and on behalf of the undersigned
Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed
with the United States Securities and Exchange Commission pursuant to Section
16(a) of the Securities Act of 1934, relating to the undersigned's beneficial
ownership of securities in Integra LifeSciences Holdings Corporation
(the "Company"). The undersigned also authorizes the above persons to execute
for and on behalf of the undersigned any Form ID or similar document required to
obtain or renew Securities and Exchange Commission electronic filings codes and
passwords and cause such form(s) to be submitted to and/or filed with the
Securities and Exchange Commission. The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

           This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys in-fact.

          IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 22nd day of June 2020.

                                                        /s/ Richard E. Caruso
                                                       Richard E. Caruso